GAMA
IONS icon

Graticule Asia Macro Advisors’s Ionis Pharmaceuticals IONS Stock Holding History

Graticule Asia Macro Advisors’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$100K Buy
+1,264
New +$95.1K 0.01% 94
2021
Q1 		– Sell
-100,000
Closed -$5.65M – 196
2020
Q4 		$5.65M Buy
+100,000
New +$4.98M 2.71% 8

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Graticule Asia Macro Advisors's IONS Position: Q2 2026 in Review

Graticule Asia Macro Advisors opened a new position in Ionis Pharmaceuticals (IONS) in Q2 2026: 1,264 shares worth $100K. The stake represents 0.01% of the portfolio and ranks #94 among its holdings. This is a return to the name: Graticule Asia Macro Advisors previously reported a position in IONS as recently as Q4 2020.

Graticule Asia Macro Advisors first reported a position in IONS in Q4 2020 and has held it in 2 quarters since. The position peaked at $5.65M in Q4 2020. 514 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Graticule Asia Macro Advisors held 1,264 shares of Ionis Pharmaceuticals worth $100K as of Q2 2026.
  • Ionis Pharmaceuticals was a new Graticule Asia Macro Advisors position in Q2 2026.
  • Ionis Pharmaceuticals made up 0.01% of Graticule Asia Macro Advisors's portfolio in Q2 2026, its #94 holding.
  • Graticule Asia Macro Advisors first reported a position in Ionis Pharmaceuticals in Q4 2020 and has held it in 2 quarters since.
  • Graticule Asia Macro Advisors's Ionis Pharmaceuticals position peaked at $5.65M in Q4 2020.
  • 514 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Graticule Asia Macro Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.